top of page
$1.65M JKTG FOUNDATION RESEARCH TAKES AIM AT METASTATIC TRIPLE-NEGATIVE BREAST CANCER
The JKTG Foundation is investing $1.65 million through 2028 in research aimed at finding better ways to treat triple-negative breast cancer (TNBC), an aggressive disease that frequently spreads to the lung and liver.
7 hours ago2 min read
bottom of page